Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
21491979	s-prlbio	mU/l (mu/l)	1754	2497	0.00%
21491979	s-prlbio	— (—)	111	117	100.00%	Distribution not available
21491979	s-prlbio	mU/l______ (mu/l)	32	40	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_CONSORTIUM

799

765

6.62

307.65

1.7

1.2

964.15

371.04

mu/l

3.63

763

726

Disorders of other endocrine glands

792

577

13.92

307.65

1.8

1.2

1009.80

378.59

mu/l

4.00

768

541

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

541

395

14.10

307.65

1.7

1.4

1035.65

474.00

mu/l

1.86

527

373

Exclusions for E4_PCOS_BROAD

730

192

41.53

307.65

1.8

1.2

1080.71

342.26

mu/l

4.50

706

183

Endocrine, nutritional and metabolic diseases

520

572

4.62

167.54

1.6

1.2

605.58

351.45

mu/l

3.43

502

539

Kela-code for severe mental illness

313

634

5.00

144.36

1.5

1.4

786.53

487.85

mu/l

2.77

292

607

Schizophrenia or delusion, excluding more controls

262

456

5.75

140.39

1.4

1.5

826.50

490.63

mu/l

3.60

243

441

Female infertility

298

294

6.17

137.79

1.3

1.5

350.36

812.28

mu/l

4.90

289

277

Unspecified mental disorder

334

750

4.50

135.82

1.4

776.10

475.26

mu/l

3.28

311

720

Amenorrhoea

141

128

11.45

133.98

1.8

1.6

638.66

815.68

mu/l

0.54

135

122

Female infertility, cervical, vaginal, other or unspecified origin

269

281

6.22

129.32

1.3

1.6

311.28

833.03

mu/l

5.69

260

266

Anxiety (asthma-related co-morbidities)

435

893

3.73

126.72

1.4

1.5

626.66

521.11

mu/l

0.56

410

863

All anxiety disorders

459

1076

3.34

114.09

1.4

626.45

476.48

mu/l

1.54

433

1031

Schizophrenia or delusion

262

560

4.74

113.46

1.4

1.5

826.50

465.76

mu/l

5.49

243

539

Schizophrenia, schizotypal and delusional disorders

262

562

4.72

112.97

1.4

1.5

826.50

465.07

mu/l

5.52

243

541

Depression

529

1147

3.10

112.01

1.4

578.04

690.77

mu/l

0.46

501

1102

Mood disorders

544

1157

3.02

108.91

1.4

547.71

688.59

mu/l

0.66

510

1111

Used for control exclusion in common control thyroid runs

545

869

3.18

108.89

1.6

1.2

882.72

484.95

mu/l

1.14

522

824

Mood [affective] disorders

543

1158

3.02

108.59

1.4

548.36

688.17

mu/l

0.65

509

1112

Other and unspecified nonorganic psychotic disorders

215

404

5.42

108.32

1.5

1.4

833.88

414.46

mu/l

8.76

197

387

Irregular menses

402

875

3.49

105.60

1.5

1.4

507.80

557.47

mu/l

0.45

383

833

Mood disorders, excluding more controls

455

848

3.17

95.79

1.4

1.5

555.01

753.44

mu/l

0.71

425

816

Neurotic, stress-related and somatoform disorders

487

1167

2.89

92.50

1.4

609.24

685.42

mu/l

0.27

460

1118

Anxiety disorders

486

1169

2.87

90.93

1.4

604.48

684.75

mu/l

0.29

459

1120

Anxiety disorders, excluding more controls

410

833

3.16

88.47

1.4

1.5

573.33

759.45

mu/l

0.62

387

802

Polycystic ovarian syndrome, consortium definition

465

905

2.97

87.22

1.5

1.4

478.92

560.48

mu/l

0.99

446

862

Other anxiety disorders

366

988

3.18

86.56

1.4

636.17

475.94

mu/l

1.42

347

946

Personality disorders, excluding more controls

225

536

4.24

84.76

1.5

617.71

482.95

mu/l

0.64

211

516

Hypothyroidism, levothyroxine purchases

243

292

4.72

84.13

1.6

1.4

591.12

510.39

mu/l

0.24

228

278

Hypothyroidism and >3 levothyroxin purchases

243

292

4.72

84.13

1.6

1.4

591.12

510.39

mu/l

0.24

228

278

Hypothyroidism (congenital or acquired)

243

292

4.71

83.99

1.6

1.4

591.29

510.39

mu/l

0.24

228

278

Disorders of the thyroid gland

480

1141

2.74

81.59

1.5

1.4

646.77

674.53

mu/l

0.07

452

1094

Hypothyroidism, other/unspecified

463

1106

2.76

80.30

1.5

1.4

630.20

653.91

mu/l

0.06

438

1061

Hypothyreosis and Thyroxine purchase for inclusion criteria

470

1146

2.70

77.85

1.5

1.4

625.41

660.61

mu/l

0.10

444

1097

Schizophrenia

124

201

6.25

73.00

1.5

893.43

353.71

mu/l

7.40

112

196

Disorders of adult personality and behaviour

248

758

3.31

65.32

1.4

1.5

602.23

500.05

mu/l

0.57

232

728

Acute and transient psychotic disorders

141

6.99

63.45

1.4

1.5

952.67

374.36

mu/l

5.77

136

Personality disorders

225

684

3.33

59.83

1.5

617.71

504.51

mu/l

0.58

211

658

Bipolar affective disorders

157

391

4.06

56.15

1.4

695.97

486.66

mu/l

1.23

147

378

Medical observation and evaluation for suspected diseases and conditions

293

505

2.98

53.53

1.4

1.5

492.80

863.36

mu/l

0.93

278

485

Specific personality disorders

199

607

3.32

52.72

1.5

1.4

521.12

494.39

mu/l

0.19

186

586

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

194

578

3.34

52.04

1.4

1.5

632.59

466.84

mu/l

1.36

179

559

Benzodiazepine use

442

1331

2.25

50.66

1.3

1.5

631.55

664.75

mu/l

0.11

417

1272

Benign neoplasms

462

1138

2.22

48.39

1.6

1.3

873.70

459.14

mu/l

1.20

450

1073

Headache

337

1067

2.45

48.38

1.4

535.29

682.17

mu/l

0.59

323

1022

Noninflammatory disorders of female genital tract

228

362

3.18

45.95

1.4

1.5

434.51

758.62

mu/l

2.96

216

342

Migraine

313

1002

2.44

44.75

1.4

533.60

513.84

mu/l

0.13

304

954

Other nutritional deficiencies

334

1322

2.32

44.00

1.5

1.4

430.84

700.67

mu/l

2.18

317

1266

Emotionally unstable personality disorder

138

381

3.68

42.86

1.4

520.71

508.11

mu/l

0.06

128

363

Other antidepressants

390

887

2.25

41.67

1.4

1.5

510.12

749.45

mu/l

0.98

367

848

Mixed and other personality disorders

133

5.74

40.47

1.4

1.5

906.61

439.69

mu/l

1.03

127

Selective serotonin reuptake inhibitors

380

892

2.22

39.63

1.4

1.5

518.28

746.01

mu/l

0.85

363

853

Obesity

310

1293

2.27

39.10

1.5

1.4

430.47

707.10

mu/l

2.17

294

1237

Ovarian dysfunction

222

4.46

39.05

1.4

1.2

369.00

387.28

mu/l

0.14

209

Obesity and other hyperalimentation

310

1296

2.26

38.74

1.5

1.4

430.47

706.57

mu/l

2.18

294

1240

Any mental disorder

374

850

2.21

38.14

1.4

1.5

506.49

753.20

mu/l

0.96

353

818

Recurrent or chronic depression

184

430

2.98

37.48

1.3

1.5

430.93

540.51

mu/l

0.68

176

418

Poisoning by medicine

154

496

3.13

37.43

1.4

662.66

478.27

mu/l

1.60

145

476

Substance abuse, excluding more controls

213

678

2.63

36.37

1.3

1.5

583.82

827.63

mu/l

0.69

198

651

Poisoning by drugs, medicaments and biological substances

161

553

2.94

35.00

1.3

1.5

660.20

476.07

mu/l

1.72

151

533

Hirsutism in women

8.06

33.45

1.2

1.4

385.44

379.95

mu/l

0.03

Hypothyroidism, strict autoimmune

269

771

2.30

32.44

1.4

1.2

513.74

451.04

mu/l

0.49

248

733

Polycystic ovarian syndrome

187

4.43

32.36

1.4

1.2

322.51

391.87

mu/l

1.00

176

Nonorganic sleeping disorders, excluding more controls

124

388

3.22

31.69

1.4

1.5

502.93

427.36

mu/l

0.42

116

374

Pain and other conditions associated with female genital organs and menstrual cycle

131

345

3.20

31.60

1.2

1.5

491.72

780.75

mu/l

1.68

124

325

Hypertrichosis

7.22

31.19

1.2

1.4

380.29

449.43

mu/l

0.42

Mental and behavioural disorders due to sedatives or hypnotics

101

5.73

30.84

1.4

556.44

413.47

mu/l

0.83

General examination and investigation of persons without complaint and reported diagnosis

237

505

2.44

30.64

1.4

1.5

484.40

863.36

mu/l

0.99

224

485

Depression medications

176

310

2.87

30.32

1.3

1.4

494.50

499.58

mu/l

0.02

166

296

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

194

797

2.45

29.68

1.4

632.59

485.04

mu/l

1.54

179

765

Excessive, frequent and irregular menstruation

184

362

2.73

29.63

1.3

1.5

444.37

758.62

mu/l

2.55

173

342

Examination and observation for other reasons

218

504

2.45

29.04

1.5

425.65

864.59

mu/l

1.22

209

484

Panic disorder

122

405

3.04

28.32

1.3

1.4

822.83

460.63

mu/l

1.28

115

387

Obesity, other/unspecified

178

719

2.49

28.24

1.6

1.4

431.41

535.48

mu/l

1.08

173

694

Special screening examination for infectious and parasitic diseases

159

428

2.73

28.09

1.4

1.5

510.71

521.83

mu/l

0.03

146

410

Suicide or other Intentional self-harm

141

509

2.79

28.07

1.4

1.5

704.06

459.28

mu/l

2.60

131

489

Malaise and fatigue

186

594

2.47

27.69

1.4

1.5

507.78

776.21

mu/l

0.73

179

571

Generalized anxiety disorder

136

489

2.80

27.25

1.4

450.71

439.96

mu/l

0.06

131

468

Other and unspecified mood [affective] disorders

175

4.18

26.89

1.4

1.5

815.55

393.56

mu/l

2.46

167

Substance use, excluding alcohol

113

372

3.06

26.60

1.3

1.5

577.94

455.75

mu/l

1.09

103

354

Episodal and paroxysmal disorders

419

1156

1.84

26.56

1.5

1.4

500.34

635.85

mu/l

0.74

398

1098

Other disorders of fluid, electrolyte and acid-base balance

221

3.63

26.01

1.3

1.4

537.35

698.22

mu/l

0.27

213

Persons encountering health services for other counselling and medical advice, not elsewhere classified

389

1116

1.86

25.55

1.4

1.5

652.37

684.12

mu/l

0.08

373

1059

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

115

394

2.95

25.29

1.4

690.51

448.50

mu/l

2.71

107

378

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

379

1332

1.83

24.87

1.4

566.83

644.60

mu/l

0.26

359

1269

Neoplasms

371

1046

1.87

24.70

1.7

1.3

662.31

459.16

mu/l

1.46

363

985

Other symptoms and signs involving cognitive functions and awareness

123

386

2.83

24.68

1.4

1.5

449.70

834.41

mu/l

0.72

115

367

Post-traumatic stress disorder

281

3.32

24.66

1.2

1.4

497.44

471.56

mu/l

0.11

269

Anaemias

126

281

2.89

23.93

1.3

1.4

458.39

510.95

mu/l

0.27

119

267

Psychiatric diseases

295

738

2.01

23.92

1.4

1.5

522.45

794.94

mu/l

0.91

276

712

Behavioural syndromes associated with physiological disturbances and physical factors

362

1345

1.82

23.90

1.4

532.84

668.74

mu/l

0.73

338

1288

Caries of enamel

359

1284

1.83

23.87

1.5

1.4

762.89

637.28

mu/l

0.27

339

1226

Phobic anxiety disorders

109

374

2.94

23.83

1.4

556.39

455.16

mu/l

0.70

101

359

Pain, not elsewhere classified

123

451

2.74

23.82

1.5

785.77

480.53

mu/l

0.92

115

434

Persons encountering health services in other circumstances, wide

393

1118

1.81

23.74

1.4

1.5

628.91

683.88

mu/l

0.15

378

1061

Symptoms and signs involving cognition, perception, emotional state and behaviour

343

1260

1.82

22.54

1.4

1.5

656.59

687.84

mu/l

0.08

331

1192

Implicit viral Sepsis, including avohilmo

103

358

2.88

21.97

1.3

1.4

748.07

498.08

mu/l

0.36

342

Depression or dysthymia

194

475

2.24

21.19

1.5

365.29

981.11

mu/l

1.75

186

461

Dental caries

305

2.95

20.89

1.5

1.4

513.11

516.33

mu/l

0.01

289

Obesity due to excess calories

211

1040

2.04

20.84

1.4

431.17

678.58

mu/l

1.41

201

995

Caries of dentine

275

3.06

20.53

1.5

520.83

521.55

mu/l

0.00

261

Substance abuse

213

979

2.03

20.51

1.3

1.4

583.82

726.00

mu/l

0.51

198

934

Use of hypnotics and sedatives

345

1108

1.78

20.45

1.4

1.5

673.29

702.31

mu/l

0.08

329

1057

Visual disturbances and blindness

184

869

2.12

20.30

1.5

1.4

612.79

715.82

mu/l

0.25

177

829

Mental and behavioural disorders due to psychoactive substance use

219

1006

2.00

20.26

1.3

1.4

575.84

720.47

mu/l

0.54

204

961

Sleep disorders (combined)

382

1152

1.73

20.23

1.5

1.4

457.37

689.87

mu/l

1.55

362

1103

Sleep disorders

340

1331

1.76

20.21

1.4

503.22

671.24

mu/l

0.98

322

1274

Alcohol dependence

279

3.02

19.57

1.2

1.5

553.09

1030.11

mu/l

0.60

266

Intestinal infectious diseases

348

1508

1.72

19.26

1.3

1.5

640.76

639.40

mu/l

0.00

331

1438

General symptoms and signs

378

1103

1.72

19.25

1.4

500.14

699.30

mu/l

1.01

358

1056

Metabolic disorders

286

939

1.83

18.73

1.4

1.5

467.39

649.84

mu/l

1.40

274

900

Procreative management

170

655

2.15

18.64

1.4

1.5

591.11

565.57

mu/l

0.05

163

628

Genitourinary diseases

190

444

2.15

18.57

1.4

1.5

572.70

1005.26

mu/l

0.79

182

424

Nonorganic sleeping disorders

124

523

2.39

18.13

1.4

502.93

497.45

mu/l

0.02

116

505

Insomnia

337

1380

1.70

17.84

1.4

504.75

672.22

mu/l

1.01

318

1316

Neurological diseases

329

949

1.74

17.66

1.5

1.4

461.56

652.28

mu/l

0.98

314

905

Non-selective monoamine reuptake inhibitors

279

2.86

17.45

1.2

1.6

560.68

1006.91

mu/l

0.56

268

Problems related to lifestyle

178

3.40

16.93

1.4

1.5

652.55

404.47

mu/l

1.81

169

Implicit Sepsis

212

820

1.91

16.57

1.3

1.5

668.12

718.05

mu/l

0.09

201

784

Visual disturbances

167

826

2.03

16.46

1.5

1.4

617.35

726.73

mu/l

0.24

160

788

Pain in joint

200

628

1.96

16.27

1.5

462.55

717.63

mu/l

1.23

192

597

Sleep apnoea

258

906

1.80

16.23

1.5

698.39

737.24

mu/l

0.06

249

862

Antihypertensive medication - note that there are other indications

329

1019

1.69

16.05

1.4

567.98

501.11

mu/l

0.55

315

971

Other special examinations and investigations of persons without complaint or reported diagnosis

198

506

1.99

15.90

1.4

1.5

469.67

861.96

mu/l

1.03

188

486

Diarrhoea and gastroenteritis of presumed infectious origin

271

1407

1.72

15.75

1.3

1.4

489.71

653.61

mu/l

1.06

258

1340

Other headache syndromes

159

783

2.03

15.72

1.4

451.32

668.40

mu/l

0.96

153

745

Implicit Sepsis, including avohilmo

242

975

1.78

15.05

1.4

1.5

653.02

706.30

mu/l

0.11

228

932

Tramadol

253

864

1.76

14.84

1.5

1.4

577.90

761.81

mu/l

0.55

244

824

Alcohol use disorder, Swedish definition

168

786

1.95

14.58

1.3

1.5

630.81

755.90

mu/l

0.32

154

749

Mental and behavioural disorders due to alcohol, excluding acute intoxication

138

660

2.08

14.58

1.2

1.5

597.80

825.08

mu/l

0.58

125

627

Alcohol use disorder, ICD-based

130

614

2.12

14.56

1.2

1.5

596.23

865.08

mu/l

0.66

117

584

Disorders of skin appendages

217

1220

1.77

14.27

1.3

1.4

486.22

664.21

mu/l

0.99

205

1163

Any reimbursement code in KELA

268

778

1.73

14.13

1.5

1.4

526.96

525.98

mu/l

0.00

256

746

Hypothyroidism, strict autoimmune, 3 medication purchases required

266

1070

1.67

13.30

1.4

514.45

670.90

mu/l

0.67

245

1022

Irritable bowel syndrome

114

531

2.16

13.29

1.4

1.5

484.35

508.63

mu/l

0.13

103

508

Other/unspecified dorsalgia

125

595

2.08

13.29

1.4

486.67

639.96

mu/l

0.62

118

566

Disorders of lipoprotein metabolism and other lipidaemias

176

563

1.90

13.23

1.4

1.5

1089.10

661.32

mu/l

0.34

169

539

Intestinal infectious diseases, including avohilmo, including avohilmo

364

1301

1.56

13.22

1.4

727.40

643.48

mu/l

0.22

349

1239

KRA_PSY_EATING, excluding more controls

296

2.57

13.07

1.2

1.5

577.11

433.44

mu/l

0.75

285

Mental and behavioural disorders due to alcohol

161

812

1.89

13.01

1.2

1.5

567.11

779.88

mu/l

0.69

148

777

Pure hypercholesterolaemia

145

461

2.00

12.71

1.5

1467.73

690.53

mu/l

0.55

140

442

188

915

1.79

12.56

1.3

1.4

608.66

728.36

mu/l

0.36

174

873

Convulsions, not elsewhere classified

101

453

2.21

12.54

1.3

1.5

511.85

479.27

mu/l

0.19

436

Mycoses, including avohilmo

317

1542

1.57

12.50

1.5

1.4

944.19

583.92

mu/l

0.57

300

1472

Other functional intestinal disorders

139

644

1.96

12.48

1.3

1.5

673.15

810.40

mu/l

0.31

125

618

Uterine polyps

160

2.71

12.48

1.3

1.6

671.78

776.26

mu/l

0.22

150

Triptan medication for migraine, min. 3 purchases

266

1229

1.62

12.06

1.4

615.12

516.57

mu/l

0.40

256

1175

Condition for Implicit Sepsis (Organ dysfunction codes)

244

1025

1.65

11.76

1.4

1.5

752.58

681.57

mu/l

0.14

231

980

Dental pulpitis, including avohilmo

341

1432

1.53

11.67

1.4

642.65

656.27

mu/l

0.03

321

1369

175

879

1.78

11.59

1.2

1.4

577.15

751.06

mu/l

0.57

162

838

Care involving use of rehabilitation procedures

184

952

1.74

11.30

1.4

556.56

782.17

mu/l

0.92

178

909

Migraine, single triptan purchase ok & required. ICD-code if available is included

294

1276

1.56

11.30

1.4

542.82

526.38

mu/l

0.06

281

1217

Triptan medication for migraine, single purchase ok

294

1276

1.56

11.30

1.4

542.82

526.38

mu/l

0.06

281

1217

Low back pain

275

1172

1.59

11.25

1.5

1.4

915.14

622.57

mu/l

0.36

263

1111

Hypertrophy of breast in women and men

335

2.34

11.14

1.4

1.5

430.56

461.40

mu/l

0.18

322

Sleep apnoea, including avohilmo

276

1054

1.58

11.03

1.5

1.4

673.16

729.47

mu/l

0.09

266

1002

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

171

848

1.77

10.96

1.3

1.4

553.22

473.49

mu/l

0.82

161

810

Fever of other and unknown origin

176

873

1.75

10.94

1.4

1.5

751.85

759.86

mu/l

0.01

165

838

Dentofacial anomalies [including malocclusion]

273

1368

1.56

10.81

1.4

572.91

520.35

mu/l

0.24

265

1303

Acute upper respiratory infections of multiple and unspecified sites

272

1270

1.56

10.67

1.4

443.60

595.56

mu/l

1.79

264

1207

Other disorders of lacrimal gland

104

511

2.04

10.64

1.4

1.5

365.90

471.85

mu/l

1.98

486

Oedema, not elsewhere classified

351

2.23

10.25

1.3

1.6

547.47

947.71

mu/l

0.62

337

Candidiasis, including avohilmo

123

650

1.90

10.24

1.5

1.4

514.87

504.45

mu/l

0.05

118

623

Endometriosis

106

297

2.08

10.19

1.2

1.5

434.45

825.13

mu/l

2.17

101

280

Neurological diseases, wide definition

145

389

1.88

10.10

1.3

1.4

497.90

627.20

mu/l

0.55

136

373

Dorsalgia

344

1229

1.48

10.01

1.5

1.4

750.19

613.93

mu/l

0.20

330

1165

Asthma (mode)

255

848

1.58

9.87

1.5

479.44

705.58

mu/l

1.45

246

815

Lower back pain or/and sciatica

344

1459

1.47

9.75

1.5

1.4

826.99

609.07

mu/l

0.33

331

1387

Heart failure, not strict

128

457

1.88

9.72

1.5

1018.09

815.33

mu/l

0.19

120

438

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

272

1199

1.53

9.67

1.4

1.5

791.81

646.47

mu/l

0.35

257

1144

Type 2 diabetes

295

1129

1.51

9.63

1.4

1.5

552.63

620.58

mu/l

0.30

280

1079

Restless leg syndrome

165

2.80

9.56

1.6

1.4

455.11

420.70

mu/l

0.09

159

Symptoms and signs involving the circulatory and respiratory systems

351

1202

1.47

9.48

1.5

1.4

472.12

631.18

mu/l

1.43

330

1149

Renal failure

304

2.19

9.34

1.3

847.80

1045.69

mu/l

0.17

288

Social phobias

237

2.47

9.33

1.3

1.4

517.37

403.69

mu/l

0.81

226

Other soft tissue disorders, not elsewhere classified

328

1274

1.47

9.15

1.4

538.11

694.73

mu/l

0.79

314

1216

Disorders of lacrimal system

119

636

1.84

9.10

1.4

1.5

374.15

495.12

mu/l

2.35

114

606

Asthma

254

846

1.55

9.04

1.5

482.71

706.29

mu/l

1.41

245

813

Asthma, excluding more controls

252

834

1.55

9.03

1.5

484.62

634.33

mu/l

0.93

243

802

Exposure to unspecified factor

328

1541

1.45

8.92

1.3

1.4

558.58

660.92

mu/l

0.51

317

1465

Persons encountering health services in other circumstances

140

796

1.74

8.90

1.3

1.5

589.44

708.03

mu/l

0.33

134

755

Abnormalities of breathing

307

1196

1.47

8.72

1.5

1.4

439.40

632.58

mu/l

2.08

293

1144

Disorders of conjunctiva

288

1517

1.47

8.71

1.4

758.94

611.73

mu/l

0.31

278

1443

Disorders of optic nerve and visual pathways

146

2.83

8.68

1.5

1070.77

411.23

mu/l

0.55

141

Asthma-related infections

189

1166

1.58

8.29

1.6

1.4

482.40

702.99

mu/l

1.26

180

1109

Asthma, hospital admission 2, infections

189

1166

1.58

8.29

1.6

1.4

482.40

702.99

mu/l

1.26

180

1109

Certain disorders involving the immune mechanism

214

2.44

8.27

1.6

1.4

509.83

478.56

mu/l

0.14

207

Conjunctivitis

269

1471

1.47

8.26

1.4

787.19

581.37

mu/l

0.44

259

1401

Acute pancreatitis

168

2.63

8.16

1.2

1.4

521.63

434.07

mu/l

0.20

161

Opioids

340

1232

1.43

8.13

1.5

1.4

476.75

669.73

mu/l

1.12

324

1175

Asthma, including avohilmo

374

1474

1.40

8.10

1.4

503.61

682.08

mu/l

1.18

362

1400

Diseases of male genital organs

112

300

1.88

8.01

1.4

700.23

1176.24

mu/l

0.50

105

286

Gastroduodenal ulcer

141

2.76

7.98

1.4

1.5

550.42

980.90

mu/l

0.48

136

Type 2 diabetes, definitions combined, including avohilmo

265

1034

1.48

7.94

1.3

1.5

580.05

642.67

mu/l

0.24

249

990

Persons encountering health services for examination and investigation

167

506

1.66

7.82

1.4

1.5

406.50

861.96

mu/l

1.30

162

486

Certain infectious and parasitic diseases

305

1059

1.44

7.76

1.4

1.5

439.88

689.25

mu/l

1.45

291

1011

Complications of medical and surgical care

195

1133

1.55

7.73

1.3

1.5

515.61

703.08

mu/l

0.89

183

1088

Dermatitis and eczema

343

1449

1.40

7.70

1.5

1.4

513.53

682.72

mu/l

1.06

325

1381

Transport accidents

174

911

1.59

7.69

1.3

1.5

932.56

636.46

mu/l

0.22

165

870

159

979

1.61

7.64

1.6

1.4

452.26

530.40

mu/l

0.76

151

933

Dysphagia

241

2.29

7.63

1.3

1.6

503.71

542.53

mu/l

0.12

234

Cutaneous abscess, furuncle and carbuncle

490

1.88

7.61

1.4

491.65

436.79

mu/l

0.25

470

Diaphragmatic hernia

286

2.17

7.60

1.3

1.5

464.46

1027.61

mu/l

0.79

273

Pain (limb, back, neck, head abdominally)

201

643

1.57

7.57

1.2

1.5

466.18

709.93

mu/l

1.17

195

611

Type 2 diabetes, strict (exclude DM1)

258

1019

1.47

7.55

1.3

1.5

578.35

638.97

mu/l

0.22

243

975

Acute pancreatitis (for exclusion)

176

2.51

7.46

1.2

1.4

521.63

434.17

mu/l

0.20

170

Type 2 diabetes, definitions combined

257

1017

1.47

7.46

1.3

1.5

579.85

637.93

mu/l

0.21

242

973

Injuries to the neck

510

1.85

7.36

1.3

1.4

437.50

501.51

mu/l

0.42

491

Codeine

312

1196

1.41

7.17

1.4

589.69

676.12

mu/l

0.29

294

1140

Other dorsopathies, not elsewhere classified

332

1236

1.40

7.13

1.5

1.4

466.49

613.85

mu/l

1.35

317

1172

Diseases of the eye and adnexa

295

1037

1.43

7.10

1.5

1.4

455.85

530.30

mu/l

0.63

282

983

Other diseases of intestines

354

1436

1.37

7.02

1.3

1.5

465.47

689.25

mu/l

1.76

327

1381

Type 2 diabetes, wide definition

151

585

1.63

7.02

1.3

1.5

1309.87

682.51

mu/l

0.45

141

556

Disorders of ocular muscles, binocular movement, accommodation and refraction

177

1141

1.54

7.00

1.3

1.4

541.69

507.39

mu/l

0.24

166

1091

Symptoms and signs involving the skin and subcutaneous tissue

209

1327

1.49

7.00

1.4

529.55

689.86

mu/l

0.83

201

1263

Other diseases of liver

188

2.40

6.98

1.2

1.4

413.36

441.70

mu/l

0.12

181

Eating disorder

392

1.95

6.96

1.2

1.4

577.11

517.53

mu/l

0.25

374

Diabetes mellitus

313

1296

1.40

6.87

1.4

552.50

605.07

mu/l

0.24

298

1237

Emotional disorders and disorders of social functioning with onset specific to childhood

204

2.33

6.86

1.3

1.4

591.40

456.03

mu/l

0.64

194

Syncope and collapse

109

525

1.74

6.77

1.4

1.5

878.51

793.52

mu/l

0.09

104

506

Acne, including avohilmo

162

839

1.57

6.73

1.4

470.37

489.17

mu/l

0.15

153

800

Diabetes, varying definitions

309

1288

1.39

6.69

1.3

1.4

554.69

605.64

mu/l

0.23

294

1230

Eating disorders

412

1.90

6.67

1.2

1.4

568.59

514.21

mu/l

0.23

394

Other and unspecified effects of external causes

112

662

1.70

6.59

1.5

1.4

599.33

495.64

mu/l

0.51

107

633

Pain in limb

274

1233

1.41

6.59

1.4

546.30

704.54

mu/l

0.74

263

1176

Erysipelas

103

510

1.74

6.54

1.3

1.5

544.71

882.97

mu/l

0.73

488

Dialysis, with operation codes

2.96

6.52

1.5

1.4

684.32

365.12

mu/l

1.82

Excessive attrition of teeth

211

1432

1.46

6.49

1.5

1.4

501.06

675.44

mu/l

0.97

197

1369

Diseases of the skin and subcutaneous tissue

295

1058

1.40

6.45

1.4

455.29

615.44

mu/l

1.29

280

1012

Hypertension, essential

190

710

1.51

6.37

1.4

1.5

482.59

555.20

mu/l

0.48

184

678

Hyperfunction of pituitary gland, other and/or unspecified

+∞

6.35

2.0

0.0

189.67

—

mu/l

—

Hypertensive diseases (excluding secondary)

167

626

1.55

6.33

1.5

525.46

573.01

mu/l

0.25

161

598

Pain in throat and chest

265

1112

1.41

6.29

1.4

821.36

648.32

mu/l

0.19

251

1063

Symptoms and signs involving the urinary system

172

853

1.52

6.25

1.4

1.5

492.25

749.70

mu/l

1.01

159

817

Use of pramipexole

161

2.43

6.25

1.7

1.4

639.79

429.43

mu/l

0.45

154

Temporomandibular joint disorders, including avohilmo

192

1263

1.48

6.22

1.3

1.4

450.36

502.88

mu/l

0.44

187

1202

Diseases of the digestive system

102

593

1.71

6.21

1.6

1.4

580.39

800.38

mu/l

0.53

565

Constipation

211

980

1.46

6.15

1.3

1.5

729.82

721.12

mu/l

0.02

191

943

Infections with a predominantly sexual mode of transmission, including avohilmo

200

1254

1.46

6.14

1.3

1.4

405.86

530.03

mu/l

2.16

193

1193

Abdominal and pelvic pain

277

996

1.40

6.03

1.3

1.5

485.67

769.76

mu/l

1.41

258

958

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

146

924

1.55

6.03

1.2

1.5

538.96

722.17

mu/l

0.65

138

884

Diseases of liver

384

1.88

6.02

1.3

1.5

401.17

859.93

mu/l

0.89

366

Menorrhagia

249

1.86

6.01

1.4

1.6

568.38

879.19

mu/l

1.08

236

Follicular cysts of skin and subcutaneous tissue

228

2.16

5.98

1.5

579.75

417.69

mu/l

0.48

219

Atopic dermatitis

230

1293

1.42

5.91

1.5

1.4

463.59

527.31

mu/l

0.64

217

1232

Nutritional anaemias

109

628

1.66

5.89

1.2

1.5

1336.26

621.20

mu/l

0.38

104

598

Gastro-oesophageal reflux disease

161

896

1.52

5.89

1.4

1.5

1075.04

659.78

mu/l

0.31

155

860

Autoimmune diseases

350

1327

1.34

5.88

1.5

1.4

752.34

636.25

mu/l

0.16

333

1266

Asthma (only as main-diagnosis), excluding more controls

218

834

1.45

5.86

1.5

484.89

634.33

mu/l

0.95

208

802

Symptoms and signs involving the nervous and musculoskeletal systems

149

974

1.53

5.84

1.3

1.4

486.70

703.79

mu/l

0.95

144

929

Asthma (only as main-diagnosis)

218

846

1.44

5.78

1.5

484.89

706.29

mu/l

1.41

208

813

Other neurological diseases

143

714

1.55

5.77

1.6

1.5

911.65

714.95

mu/l

0.23

138

679

Hypertension

199

767

1.46

5.73

1.4

1.5

489.94

549.91

mu/l

0.41

192

732

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

125

683

1.59

5.73

1.3

1.5

747.96

741.45

mu/l

0.01

120

652

Other disorders of eye and adnexa

239

2.10

5.72

1.2

1.5

422.87

419.29

mu/l

0.02

229

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

140

874

1.55

5.71

1.4

1.5

1236.66

606.47

mu/l

0.44

134

834

Complications of procedures, not elsewhere classified

219

1244

1.42

5.69

1.3

1.5

499.20

732.76

mu/l

1.36

204

1190

Mouth breathing

515

1.73

5.68

1.4

346.90

819.81

mu/l

1.39

493

Iron deficiency anaemia

579

1.68

5.68

1.2

1.5

463.73

501.58

mu/l

0.26

552

Dorsopathies

330

1245

1.34

5.67

1.5

1.4

472.55

610.54

mu/l

1.22

317

1181

Hypertensive diseases

199

769

1.46

5.67

1.4

1.5

489.94

549.37

mu/l

0.40

192

734

Endometriosis diagnosis and infertility diagnosis occurring together

247

2.08

5.65

1.2

1.6

326.78

489.49

mu/l

2.25

237

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

122

377

1.63

5.46

1.3

1.5

423.12

824.76

mu/l

1.40

115

366

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

275

1579

1.36

5.45

1.5

1.4

606.62

652.37

mu/l

0.12

260

1507

Bronchitis

325

1466

1.33

5.43

1.4

484.89

690.01

mu/l

1.41

313

1394

Osteopathies and chondropathies

130

765

1.55

5.42

1.4

597.35

713.74

mu/l

0.31

125

731

Cervical disc disorders

334

1.89

5.41

1.9

1.5

427.57

745.85

mu/l

0.92

315

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

134

871

1.54

5.37

1.2

1.5

492.20

695.68

mu/l

0.75

128

830

GASTRO-related operations

276

1013

1.37

5.34

1.4

1.5

473.71

607.03

mu/l

1.07

265

968

Any gastric operation

276

1013

1.37

5.34

1.4

1.5

473.71

607.03

mu/l

1.07

265

968

Other (not insulin) diabetes medications

252

1072

1.38

5.32

1.4

1.5

571.91

750.87

mu/l

0.65

236

1026

Inflammatory diseases of female pelvic organs

231

1135

1.39

5.32

1.4

509.65

540.55

mu/l

0.18

216

1089

Cystitis

250

1078

1.38

5.29

1.5

1.4

627.29

685.68

mu/l

0.16

236

1034

Dipeptidyl peptidase 4 (DPP-4) inhibitors

317

1.81

5.24

1.3

1.6

754.99

1157.71

mu/l

0.40

304

Concussion

158

825

1.49

5.24

1.4

944.25

686.01

mu/l

0.29

151

786

Infections of the skin and subcutaneous tissue

183

1261

1.43

5.13

1.4

533.63

696.42

mu/l

0.76

174

1200

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

266

1325

1.35

5.12

1.4

1128.07

592.34

mu/l

0.74

255

1261

Symptoms and signs involving the digestive system and abdomen

270

996

1.36

5.06

1.3

1.5

487.84

769.76

mu/l

1.39

250

958

Lumbar disc prolapse

159

799

1.47

5.06

1.4

1.5

659.08

695.71

mu/l

0.06

152

757

Persons encountering health services for specific procedures and health care

330

1484

1.31

5.05

1.3

1.4

603.38

661.91

mu/l

0.22

318

1409

Codeine or tramadol medication

331

1368

1.31

5.04

1.4

590.84

643.71

mu/l

0.18

312

1305

Injuries to the head

335

1520

1.31

5.00

1.4

531.75

669.54

mu/l

0.71

323

1445

Disorders of breast

159

959

1.46

4.95

1.4

584.96

558.90

mu/l

0.07

153

917

Infections with a predominantly sexual mode of transmission

139

932

1.49

4.88

1.3

1.5

399.74

547.26

mu/l

1.97

134

884

Alcohol abuse, main dg, excluding more controls

202

2.09

4.78

1.3

1.6

535.89

335.60

mu/l

1.13

195

Trigeminal neuralgia

3.28

4.74

1.4

1.7

498.06

453.81

mu/l

0.10

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

187

1279

1.40

4.72

1.4

560.47

536.89

mu/l

0.12

178

1223

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

226

1517

1.36

4.69

1.3

1.4

724.24

602.56

mu/l

0.32

216

1445

Soft tissue disorders

328

1290

1.30

4.67

1.5

1.4

493.90

692.54

mu/l

1.16

314

1231

Dermatophytosis, including avohilmo

187

1312

1.40

4.67

1.6

1.4

1172.00

608.95

mu/l

0.52

173

1251

Erosion of teeth , including avohilmo

106

680

1.56

4.64

1.4

625.41

475.52

mu/l

0.59

653

Complications of surgical and medical care, not elsewhere classified

270

1358

1.33

4.60

1.3

1.4

516.24

705.25

mu/l

1.10

254

1294

Injuries to the ankle and foot

244

1559

1.34

4.55

1.4

537.27

667.88

mu/l

0.70

235

1483

Parasetamol

245

919

1.35

4.44

1.3

1.4

461.98

764.06

mu/l

1.45

237

874

Biguanides

231

1032

1.35

4.40

1.3

1.5

534.54

765.09

mu/l

0.88

215

989

Injuries to the abdomen, lower back, lumbar spine and pelvis

103

658

1.54

4.32

1.5

1.4

634.55

513.88

mu/l

0.54

635

Bacterial infection, other or unspecified, including avohilmo

112

603

1.52

4.29

1.3

1.5

798.48

724.87

mu/l

0.08

107

574

Specific development disorders of scholastic skills

143

2.21

4.20

1.4

1.3

557.25

462.55

mu/l

0.29

137

Exposure to other specified factors

247

1610

1.32

4.20

1.3

1.4

544.41

659.32

mu/l

0.63

234

1536

Viral infections characterized by skin and mucous membrane lesions

114

761

1.50

4.18

1.6

1.4

562.12

474.63

mu/l

0.41

108

727

Dermatitis

159

1106

1.41

4.18

1.6

1.4

542.64

718.39

mu/l

0.74

154

1051

Other intervertebral disc disorders

204

891

1.37

4.16

1.4

593.86

679.05

mu/l

0.19

195

844

Dyspnoea

224

1208

1.34

4.15

1.6

1.4

468.40

749.04

mu/l

1.88

214

1151

Provisional assignment of new diseases of uncertain etiology

160

1135

1.40

4.09

1.3

1.4

502.59

666.03

mu/l

0.76

153

1080

Codes for special purposes

160

1137

1.40

4.05

1.3

1.4

502.59

665.40

mu/l

0.76

153

1082

Allergic conjunctivitis

193

1372

1.35

4.03

1.4

561.11

540.58

mu/l

0.11

184

1315

Intracranial trauma

175

853

1.39

4.02

1.4

899.97

675.26

mu/l

0.27

167

814

Strabismus

536

1.58

4.01

1.4

623.66

493.51

mu/l

0.70

515

Abnormalities of heart beat

574

1.56

4.01

1.4

571.06

647.29

mu/l

0.23

551

Maltreatment syndromes

130

2.25

3.99

1.6

1.4

750.97

399.58

mu/l

0.90

125

Acute upper respiratory infections

282

1308

1.29

3.97

1.4

984.72

590.93

mu/l

0.50

273

1244

Diseases of inner ear

614

1.53

3.94

1.6

1.5

577.28

799.53

mu/l

0.47

582

Other eating disorders

219

1.93

3.91

1.2

1.4

516.85

548.39

mu/l

0.08

209

Other disorders of skin and subcutaneous tissue

155

935

1.40

3.91

1.5

1.4

1111.42

603.25

mu/l

0.38

149

892

First line medication for Crohn's disease

330

1404

1.26

3.85

1.5

1.4

513.86

675.31

mu/l

0.92

321

1332

Benign neoplasm: Colon

392

1.65

3.85

1.6

1.4

1979.56

710.63

mu/l

0.40

379

Intracranial injury

160

1078

1.38

3.83

1.4

579.82

712.39

mu/l

0.36

152

1018

Premenstrual syndrome

4.35

3.83

1.0

1.4

1005.67

749.21

mu/l

0.12

Short stature starting before birth

9.11

3.81

1.3

1.5

551.43

434.88

mu/l

—

Statin medication

198

825

1.35

3.80

1.3

1.5

549.60

505.10

mu/l

0.29

192

784

Asthma (diagnoses ohter than nonallergic)

251

1566

1.29

3.78

1.5

1.4

483.28

674.81

mu/l

1.37

240

1494

Congenital malformations, deformations and chromosomal abnormalities

207

1483

1.32

3.74

1.3

1.4

604.33

558.68

mu/l

0.15

199

1412

Erysipelas, including avohilmo

140

732

1.42

3.74

1.4

1.5

522.06

770.15

mu/l

0.76

134

694

Conjunctivitis (acute, non atopic), including avohilmo

276

1300

1.28

3.69

1.4

741.32

646.60

mu/l

0.17

270

1232

Acute alcohol intoxication

356

1.69

3.67

1.3

1.5

508.29

910.94

mu/l

0.65

341

Chronic periodontitis, complicated

621

1.51

3.66

1.3

1.5

485.99

824.90

mu/l

1.01

593

Chronic rhinitis, nasopharyngitis and pharyngitis

598

1.52

3.66

1.5

323.60

513.86

mu/l

3.09

574

Diseases of external ear

551

1.55

3.64

1.2

1.4

492.77

502.88

mu/l

0.04

527

Abrasion of teeth

552

1.54

3.62

1.7

1.4

529.94

453.07

mu/l

0.35

526

Other metabolic disorders

197

1.93

3.61

1.2

1.5

489.32

453.57

mu/l

0.13

188

Postprocedural endocrine and metabolic disorders, not elsewhere classified

184

1.96

3.57

1.2

1.5

506.14

464.29

mu/l

0.15

176

Viral and other specified intestinal infections, including avohilmo

127

863

1.42

3.55

1.3

1.5

702.44

485.64

mu/l

0.51

122

827

Injuries to the thorax

619

1.50

3.52

1.3

1.5

1614.00

671.83

mu/l

0.42

589

Allergic rhinitis

125

873

1.42

3.48

1.3

1.5

453.92

506.96

mu/l

0.41

120

831

Vasomotor and allergic rhinitis

137

963

1.39

3.46

1.4

483.01

506.88

mu/l

0.16

132

921

All chronic kidney diseases

107

586

1.46

3.38

1.4

1.5

669.98

767.31

mu/l

0.13

102

562

Benign neoplasm of colon, rectum, anus and anal canal

452

1.53

3.36

1.5

2142.11

676.43

mu/l

0.59

435

Nonsuppurative otitis media, including avohilmo

143

900

1.38

3.33

1.3

1.4

483.15

480.24

mu/l

0.02

130

862

Bleeding

159

821

1.36

3.32

1.4

1.5

542.59

773.42

mu/l

0.79

153

782

Acute suppurative otitis media

133

896

1.39

3.27

1.3

1.4

711.05

502.72

mu/l

0.50

127

860

Gingivitis and periodontal diseases

237

953

1.28

3.20

1.5

1.4

486.18

541.54

mu/l

0.33

227

907

Diseases of oesophagus, stomach and duodenum

280

1318

1.25

3.19

1.3

1.5

870.36

642.60

mu/l

0.28

263

1260

Nerve, nerve root and plexus disorders

268

1278

1.26

3.17

1.5

1.4

770.36

665.81

mu/l

0.17

253

1221

Missing teeth due to accident, extraction or parodontitis

102

631

1.44

3.17

1.3

1.5

443.80

813.07

mu/l

1.17

603

Fracture of rib(s), sternum and thoracic spine

296

1.69

3.14

1.4

425.98

497.71

mu/l

0.31

281

Chronic diseases of tonsils and adenoids

238

1178

1.27

3.14

1.4

805.97

590.47

mu/l

0.37

225

1123

Diseases of middle ear and mastoid

212

1346

1.29

3.13

1.3

1.4

626.82

482.95

mu/l

0.53

199

1282

Diabetes medication

284

1329

1.25

3.11

1.3

1.5

546.96

698.79

mu/l

0.66

269

1273

Other diseases of urinary system

263

1172

1.26

3.09

1.4

584.67

686.31

mu/l

0.34

249

1125

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

194

938

1.31

3.06

1.4

603.82

512.75

mu/l

0.38

184

897

Disorders of eyelid, lacrimal system and orbit

207

1178

1.29

3.04

1.5

1.4

448.49

704.21

mu/l

1.70

197

1123

Spondylopathies

147

640

1.36

3.03

1.5

1216.81

695.24

mu/l

0.35

140

606

Appendectomy

189

1389

1.30

3.02

1.4

436.61

692.70

mu/l

1.86

181

1321

Haemorrhage, not elsewhere classified

4.30

2.99

1.4

1.3

584.33

308.43

mu/l

—

Secondary parkinsonism, excluding more controls

10.04

2.98

1.0

1.4

1046.80

362.00

mu/l

—

Cerebrovascular diseases

459

1.45

2.96

1.5

787.75

892.07

mu/l

0.09

441

Certain infectious and parasitic diseases, including avohilmo

180

686

1.32

2.91

1.4

1.5

501.79

591.46

mu/l

0.38

174

658

Other strabismus

467

1.52

2.88

1.5

1.4

590.12

507.12

mu/l

0.33

448

Other bacterial diseases

208

1077

1.28

2.88

1.4

664.59

707.79

mu/l

0.08

197

1026

Other obstetric conditions, not elsewhere classified

194

949

1.29

2.87

1.4

603.82

513.69

mu/l

0.38

184

908

Other specific joint derangements/joint disorders

251

1252

1.25

2.84

1.4

446.88

725.35

mu/l

1.89

239

1191

Shoulder lesions

153

688

1.33

2.82

1.3

1.5

579.86

870.66

mu/l

0.85

146

656

Motor disorders, excluding more controls

4.06

2.82

1.7

1.5

672.11

282.53

mu/l

—

Abnormal findings on antenatal screening of mother

409

0.49

2.75

1.4

1.5

252.70

575.43

mu/l

5.49

390

Asthma, hospital admissions , main diagnosis only

229

1597

1.25

2.70

1.5

1.4

486.04

651.10

mu/l

1.20

218

1523

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

3.77

2.67

1.6

1.3

538.67

771.96

mu/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

601

1.43

2.66

1.3

1.4

835.94

538.70

mu/l

0.59

577

Cardiovascular diseases (excluding rheumatic etc)

255

1179

1.24

2.64

1.4

460.57

544.02

mu/l

1.01

247

1125

Alcohol abuse, main dg

250

1.68

2.64

1.3

1.4

535.89

447.80

mu/l

0.33

242

Diseases of pulp and periapical tissues, including avohilmo

291

1233

1.22

2.61

1.4

460.48

521.10

mu/l

0.79

276

1177

Urticaria and erythema

109

802

1.36

2.52

1.5

1.4

762.32

503.69

mu/l

0.40

104

768

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

183

1120

1.27

2.50

1.6

1.4

462.83

548.16

mu/l

0.86

178

1067

Desensitization to allergens

152

1.85

2.42

1.3

1.4

660.68

417.54

mu/l

0.68

146

Zoster [herpes zoster]

159

1.83

2.42

1.6

1.4

513.53

431.87

mu/l

0.22

153

Cardiovascular diseases

260

1133

1.22

2.34

1.4

463.69

546.21

mu/l

0.97

249

1082

All influenza

402

1.49

2.34

1.5

1.4

456.77

834.05

mu/l

0.79

387

Unspecified lump in breast

192

1.72

2.29

1.5

1.4

643.52

470.45

mu/l

0.38

185

Hypermobility syndrome

134

1.88

2.26

1.1

1.5

318.36

416.37

mu/l

0.62

129

L04AA Selective immunosuppressants

334

1.53

2.23

1.3

1.5

515.88

480.67

mu/l

0.17

320

Urinary track infection

206

832

1.24

2.20

1.5

1.4

619.90

514.58

mu/l

0.44

193

798

Non-invasive ventilation

281

0.49

2.20

1.3

1.5

737.19

734.86

mu/l

0.00

272

Gestational diabetes (for exclusion)

180

990

1.25

2.19

1.4

512.59

531.92

mu/l

0.06

174

944

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

206

989

1.24

2.19

1.3

1.5

558.35

617.71

mu/l

0.20

195

944

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

218

1.65

2.17

1.4

478.58

443.87

mu/l

0.15

211

Suppurative and unspecified otitis media

154

1078

1.27

2.15

1.3

1.4

658.95

496.31

mu/l

0.44

148

1033

Meralgia paraesthetica

3.01

2.15

1.0

1.6

500.67

476.13

mu/l

—

Unspecified privation

137

1.83

2.13

1.4

757.24

380.78

mu/l

1.72

132

Sequelae of injuries, of poisoning and of other consequences of external causes

355

1.50

2.10

1.2

1.5

621.96

422.21

mu/l

0.69

343

Chronic lower respiratory diseases

338

1514

1.18

2.10

1.4

544.86

668.06

mu/l

0.69

323

1442

Unspecified fall

118

890

1.30

2.08

1.2

1.4

775.08

672.05

mu/l

0.18

113

849

Other bursitis of hip

5.02

2.07

1.0

2.2

403.40

316.00

mu/l

—

Periapical abscess

101

761

1.33

2.06

1.3

1.5

439.86

759.82

mu/l

1.15

726

Undetermined asthma

183

1.70

2.06

2.3

1.4

373.61

414.36

mu/l

0.23

173

Undetermined asthma, excluding more controls

183

1.70

2.06

2.3

1.4

373.61

415.06

mu/l

0.24

173

Rotator cuff syndrome

502

1.34

2.06

1.3

1.5

575.98

937.91

mu/l

0.76

479

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

199

1.66

2.04

1.5

1.4

480.36

422.34

mu/l

0.26

192

Acute alcohol intoxication, ICD10

334

1.50

2.02

1.3

1.4

570.56

436.55

mu/l

0.66

322

Other acute lower respiratory infections

136

1018

1.27

2.02

1.4

501.35

681.51

mu/l

0.69

129

970

Other facial nerve disorders

3.09

2.01

1.4

1.5

1059.25

337.12

mu/l

—

Anosmia

4.80

2.00

1.0

327.40

793.30

mu/l

—

Injuries to the wrist and hand

280

1570

1.18

1.96

1.3

1.4

614.09

650.75

mu/l

0.11

269

1495

Type 1 diabetes

462

1.41

1.91

1.4

1.5

449.17

486.99

mu/l

0.18

441

Other disorders of urethra and urinary system

179

1013

1.23

1.91

1.4

537.72

702.07

mu/l

0.65

168

972

Crushed, pushed or stepped on by crowd or human stampede

173

1.68

1.89

1.0

1.4

1178.42

457.93

mu/l

0.39

166

Other joint disorders

288

1276

1.18

1.86

1.5

1.4

405.83

718.30

mu/l

2.53

276

1214

Other condition

221

1.59

1.84

1.3

1.4

1256.10

453.53

mu/l

0.68

215

Other diseases of upper respiratory tract

275

1214

1.18

1.84

1.5

1.4

1021.31

584.55

mu/l

0.54

260

1159

Tonsillectomy and adenotomy

225

1310

1.20

1.83

1.4

1211.27

526.43

mu/l

0.75

215

1250

Diabetes, insulin treatment (Kela reimbursement)

211

1045

1.20

1.77

1.3

1.5

564.34

744.49

mu/l

0.61

200

1000

Diseases of the musculoskeletal system and connective tissue

189

779

1.22

1.77

1.4

465.48

660.13

mu/l

1.07

180

741

Excessive earwax

115

819

1.27

1.75

1.3

1.5

475.58

778.60

mu/l

1.24

110

783

Erosion and ectropion of cervix uteri

3.35

1.75

1.3

1.4

255.17

698.89

mu/l

—

Specific developmental disorder of motor function

2.52

1.74

1.7

1.2

672.11

388.01

mu/l

—

Arnold-Chiari syndrome

2.95

1.73

1.1

1.4

531.00

389.12

mu/l

—

Herpesviral [herpes simplex] infections, including avohilmo

619

1.33

1.72

1.4

865.92

510.88

mu/l

0.40

590

Puerperal sepsis

140

1.72

1.71

1.3

1.4

580.71

442.74

mu/l

0.59

134

Chronic apical periodontitis

302

1458

1.16

1.70

1.4

1074.31

509.13

mu/l

0.87

290

1388

Faecal incontinence

2.30

1.70

1.5

1.6

350.82

435.45

mu/l

0.32

Other disorders of the genitourinary system

2.06

1.70

1.1

1.5

277.53

465.52

mu/l

1.12

Anomalies of dental arch relationship, including avohilmo

513

1.34

1.69

1.3

1.4

732.06

494.29

mu/l

0.79

490

Inguinal hernia

579

0.73

1.67

1.6

1.4

406.45

888.44

mu/l

1.47

548

Insulin, intermediate and long-acting

727

1.29

1.65

1.3

1.5

418.76

799.20

mu/l

1.48

694

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.34

1.65

1.2

1.6

467.36

540.82

mu/l

0.17

Diabetic retinopathy

320

0.66

1.62

1.5

1.3

481.41

953.23

mu/l

0.78

302

Acute sinusitis

156

1166

1.22

1.61

1.4

442.68

556.07

mu/l

1.28

148

1109

Molar incisor enamel hypoplasia, with caries

3.01

1.57

1.2

384.50

461.85

mu/l

—

Other arthrosis

391

1.32

1.51

1.4

1.5

503.85

1072.62

mu/l

1.04

370

Postpartum haemorrhage due to anatomy

400

1.38

1.50

1.1

1.4

1015.25

384.09

mu/l

0.75

382

Spondyloarthritis

258

1.47

1.49

1.2

1.5

413.61

437.08

mu/l

0.12

247

Open wound of ankle and foot

170

1.59

1.48

1.1

1.4

598.41

424.29

mu/l

0.83

163

Injuries to the knee and lower leg

321

1520

1.14

1.47

1.4

541.32

666.31

mu/l

0.59

306

1450

Embedded and impacted teeth

142

951

1.21

1.44

1.3

1.4

607.84

498.17

mu/l

0.32

137

907

Haemorrhoids and perianal venous thrombosis

392

1.37

1.43

1.3

1.5

402.97

904.65

mu/l

1.03

375

Hypoplasia of dental enamel

2.74

1.43

1.2

384.50

453.27

mu/l

—

Other juvenile arthritis

110

1.74

1.43

2.2

1.3

653.47

449.38

mu/l

0.80

103

Excluding asthma or asthma-COPD overlap

201

853

1.18

1.42

1.4

1.5

511.67

706.23

mu/l

0.99

192

820

Cardiac arrest

2.32

1.42

1.4

1.5

483.33

506.61

mu/l

—

Juvenile arthritis (FINNGEN)

126

1.67

1.40

2.3

1.4

617.14

440.22

mu/l

0.74

119

Disorders of gallbladder, biliary tract and pancreas

205

1088

1.17

1.39

1.5

550.58

728.54

mu/l

0.80

194

1040

ILD medications: prednisolone, methylprednisolone, prednisone

292

1421

1.14

1.37

1.5

1.4

515.19

688.09

mu/l

1.03

283

1348

Other bacterial diseases, including avohilmo

243

1313

1.15

1.37

1.4

676.37

693.05

mu/l

0.03

230

1248

COPD differential diagnosis

199

848

1.18

1.36

1.4

1.5

524.95

705.58

mu/l

0.88

190

815

Other and unspecified trigeminal disorders

2.96

1.36

1.4

1.5

11766.60

600.06

mu/l

—

ILD differential diagnosis

199

848

1.18

1.36

1.4

1.5

524.95

705.58

mu/l

0.88

190

815

Other pulmonary diagnosis

200

853

1.17

1.35

1.4

1.5

519.83

706.23

mu/l

0.93

191

820

Gonarthrosis

426

1.26

1.32

1.4

467.14

1027.18

mu/l

1.22

402

Systemic connective tissue disorders

454

1.32

1.30

1.3

1.5

404.49

447.06

mu/l

0.28

432

Abnormal findings in secretions and smears from cervix uteri vagina vulva

167

1040

1.18

1.30

1.6

1.4

475.13

545.20

mu/l

0.65

162

991

Internal derangement of knee

632

1.27

1.30

1.3

1.4

412.20

876.14

mu/l

1.69

602

Diseases of the ear and mastoid process

313

1388

1.13

1.26

1.4

591.21

680.81

mu/l

0.30

297

1327

Diabetic retinopathy, excluding more controls

253

0.68

1.26

1.5

1.4

506.45

1074.81

mu/l

0.74

239

Diverticular disease of intestine

418

1.27

1.26

1.4

1.6

360.38

1006.08

mu/l

1.56

403

Motor disorders

2.05

1.26

1.7

1.1

672.11

381.75

mu/l

—

Gastrointestinal diseases

195

837

1.17

1.25

1.4

1.5

544.70

694.65

mu/l

0.69

188

803

Allergic asthma (mode)

618

1.26

1.25

1.3

1.4

495.21

543.99

mu/l

0.20

595

Coxibs

306

1.29

1.23

1.3

1.5

366.07

736.66

mu/l

2.26

290

Presence of other devices

184

1.50

1.23

1.2

1.4

439.96

550.35

mu/l

0.31

174

Type of accident

538

1.28

1.22

1.3

1.4

897.83

499.67

mu/l

0.67

519

Maternal care for known or suspected abnormality of pelvic organs

685

0.80

1.22

1.3

1.5

327.49

533.00

mu/l

3.55

656

Atypical facial pain

2.05

1.22

1.6

572.60

465.71

mu/l

—

Allergic asthma (mode), excluding more controls

622

1.26

1.20

1.3

1.5

495.21

547.29

mu/l

0.21

599

Pollen allergy

613

1.26

1.17

1.3

1.4

504.95

505.12

mu/l

0.00

589

Renal tubulo-interstitial diseases

206

1312

1.15

1.17

1.4

1.5

552.18

701.67

mu/l

0.51

195

1255

Ventral hernia

206

1.46

1.17

1.4

1.5

325.83

533.69

mu/l

1.12

199

Other fall from one level to another

456

1.29

1.13

1.4

525.41

469.93

mu/l

0.24

437

Lichen sclerosus et atrophicus

1.69

1.13

1.8

1.5

444.40

424.09

mu/l

0.08

Diseases of appendix

184

1425

1.15

1.13

1.4

437.76

707.71

mu/l

1.99

175

1355

Necrosis of pulp, including avohilmo

155

1311

1.17

1.13

1.3

1.5

830.76

677.80

mu/l

0.17

150

1244

Other systemic involvement of connective tissue (FG)

320

1.35

1.13

1.2

1.5

392.60

451.50

mu/l

0.34

304

Appendicitis, broad definition

183

1424

1.15

1.11

1.4

439.79

708.15

mu/l

1.97

174

1354

Other sexually transmitted chlamydial diseases

259

1.39

1.11

1.3

1.4

450.38

450.47

mu/l

0.00

244

Benign neoplasm of ovary

135

1.56

1.11

1.2

1.4

458.50

477.70

mu/l

0.08

130

Asthma and allergy

401

1.31

1.09

1.3

1.4

550.06

505.77

mu/l

0.13

385

Acute appendicitis, no complications

147

1251

1.17

1.08

1.4

453.88

693.59

mu/l

1.38

139

1189

Type 1 diabetes, wide definition, subgroup 1

407

1.30

1.08

1.4

1.5

451.81

490.77

mu/l

0.16

389

ILD medications

306

1476

1.12

1.08

1.5

1.4

486.50

676.57

mu/l

1.31

296

1401

Malignant neoplasm of breast, ER-negative, including Hilmo

150

1.50

1.07

1.7

1.5

385.92

518.86

mu/l

0.93

145

Sub-endpoint used in defining T1D endpoints

507

1.26

1.05

1.4

447.60

501.36

mu/l

0.29

487

Delayed milestone in childhood

1.98

1.04

1.6

1.1

477.00

451.63

mu/l

—

Nonsuppurative otitis media

100

721

1.20

1.03

1.4

500.56

485.04

mu/l

0.07

689

Type 1 diabetes, wide definition

419

1.29

1.03

1.4

1.5

475.44

490.77

mu/l

0.06

401

Type 1 diabetes, strict definition, subgroup 1

202

0.59

1.02

1.3

1.4

402.08

402.42

mu/l

0.00

190

Other cataract

265

1.32

1.01

1.5

1.4

419.11

793.60

mu/l

0.85

250

Pregnancy examination and test

419

1.23

1.00

1.3

1.5

402.42

548.78

mu/l

1.52

403

Asthma and allergy, excluding more controls

407

1.29

1.00

1.3

1.4

550.06

516.46

mu/l

0.09

391

Malignant neoplasm of breast, HER-negative

133

1.52

1.00

1.6

1.4

348.10

527.83

mu/l

1.50

128

Falls/tendency to fall

299

1345

1.11

1.00

1.4

502.60

684.44

mu/l

1.07

290

1280

Supervision of high-risk pregnancy

439

1.22

1.00

1.3

1.5

344.99

558.67

mu/l

4.72

423

Arthropathies

282

1276

1.12

1.00

1.5

1.4

407.81

718.30

mu/l

2.50

276

1214

Acute appendicitis

172

1394

1.14

0.99

1.3

1.4

452.88

713.37

mu/l

1.79

164

1324

Other systemic involvement of connective tissue

336

1.31

0.96

1.3

1.5

392.60

444.69

mu/l

0.29

317

Accidents

210

931

1.13

0.93

1.4

1.5

489.15

642.38

mu/l

0.88

201

889

Acute tubulo-interstitial nephritis

139

1015

1.16

0.92

1.4

419.40

696.73

mu/l

1.62

133

969

Inflammatory disorders of breast

184

1.42

0.91

1.3

1.5

656.65

471.25

mu/l

0.61

174

Paroxysmal tachycardia

288

1.30

0.91

1.6

498.13

445.73

mu/l

0.22

280

Type 1 diabetes, strict definition

204

0.63

0.86

1.3

1.4

504.08

400.82

mu/l

0.38

192

External causes of morbidity and mortality

172

758

1.14

0.86

1.4

1.5

535.42

571.91

mu/l

0.15

163

729

Spondylopathies (FG)

238

1.35

0.85

1.1

1.5

426.34

437.11

mu/l

0.05

227

Later onset COPD

0.53

0.84

1.2

1.4

365.00

623.93

mu/l

—

Abnormalities of forces of labour

227

0.66

0.84

1.2

1.6

453.40

478.06

mu/l

0.06

213

All kidney diseases

247

1494

1.11

0.83

1.4

518.06

678.37

mu/l

0.69

235

1425

Colorectal adenocarcinoma

111

0.53

0.83

1.2

1.4

5492.33

653.19

mu/l

—

103

False labour

109

786

0.86

0.82

1.2

1.5

618.54

542.24

mu/l

0.17

103

754

Viral warts, including avohilmo

526

1.22

0.80

1.6

1.4

539.48

500.89

mu/l

0.12

505

Suppurative otitis media, unspecified

1.71

0.80

1.1

1.2

685.13

322.64

mu/l

—

Enlarged lymph nodes

215

1.35

0.80

1.2

1.5

332.21

407.44

mu/l

0.86

205

Embedded teeth, including avohilmo

338

1.27

0.80

1.3

1.4

455.70

534.00

mu/l

0.38

320

Colorectal cancer, including Hilmo

137

0.61

0.79

1.1

1.4

3749.11

658.76

mu/l

—

129

Other external causes of accidental injury

207

931

1.11

0.76

1.4

1.5

491.40

642.38

mu/l

0.86

199

889

217

1143

1.11

0.76

1.3

1.5

602.64

586.00

mu/l

0.08

201

1094

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

217

1143

1.11

0.76

1.3

1.5

602.64

586.00

mu/l

0.08

201

1094

Chondropathies

252

1.31

0.76

1.4

563.03

463.32

mu/l

0.32

243

Diabetic maculopathy

219

0.69

0.74

1.4

1.3

378.17

483.59

mu/l

0.39

208

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

104

565

1.16

0.74

1.4

1.5

527.19

594.46

mu/l

0.31

541

Malignant neoplasm of bronchus and lung, including Hilmo

0.56

0.73

1.2

1.3

292.83

616.78

mu/l

—

Gonarthrosis [arthrosis of knee](FG)

101

500

1.16

0.73

1.4

1.5

470.58

937.58

mu/l

1.16

471

Other respiratory diseases principally affecting the interstitium

100

1.50

0.72

1.1

1.5

509.27

386.01

mu/l

0.38

Diabetic maculopathy, excluding more controls

109

1.47

0.70

1.4

378.17

384.71

mu/l

0.02

104

Insulin, combination of fast acting with intermediate-acting or long-acting

103

812

1.15

0.70

1.3

1.5

409.24

788.29

mu/l

1.73

777

COPD/asthma related infections

250

1143

1.10

0.69

1.4

1.5

492.82

586.00

mu/l

0.66

237

1094

COPD/asthma/ILD related infections

250

1143

1.10

0.69

1.4

1.5

492.82

586.00

mu/l

0.66

237

1094

Endometriosis of intestine

1.86

0.68

1.0

1.5

172.72

733.63

mu/l

—

Infections of breast associated with childbirth

110

1.46

0.68

1.3

1.4

315.85

403.56

mu/l

0.81

105

Diseases of pulp and periapical tissues and dental caries

112

501

1.15

0.68

1.2

1.5

378.48

471.66

mu/l

1.12

107

481

Other diseases of the respiratory system

136

1.40

0.66

1.4

423.32

389.41

mu/l

0.11

131

Other respiratory disorders and diseases

136

1.40

0.66

1.4

423.32

389.41

mu/l

0.11

131

Contact with machinery

0.53

0.66

1.4

1089.40

361.01

mu/l

—

Malignant neoplasm of prostate

107

0.66

1.1

1.4

379.83

895.86

mu/l

0.75

100

Benign lipomatous neoplasm

303

1.25

0.66

2.1

1.4

464.53

428.41

mu/l

0.15

289

Other congenital malformations of skin, including avohilmo

145

1.38

0.65

1.5

1.4

779.40

470.98

mu/l

0.82

138

Other arrhythmias

131

868

1.13

0.65

1.5

1.4

548.22

591.22

mu/l

0.15

126

827

Pneumonia, organism unspecified

214

1338

1.10

0.64

1.3

1.4

601.57

700.91

mu/l

0.42

197

1278

Childhood asthma (age<16)

472

1.18

0.64

1.3

1.4

512.09

519.42

mu/l

0.03

455

Other complications of labour and delivery, not elsewhere classified

561

1.17

0.64

1.2

1.5

284.32

514.64

mu/l

10.35

539

Palatinal maxillary operation

1.73

0.64

1.0

1.1

524.60

760.01

mu/l

—

Diabetic retinopathy, strict definition

270

0.76

0.64

1.5

1.3

401.26

920.26

mu/l

0.77

256

Type1 diabetes, definitions combined, early onset

200

0.70

0.64

1.4

570.50

420.56

mu/l

0.58

192

Colorectal cancer

126

0.61

0.63

1.1

1.4

4197.75

672.20

mu/l

—

118

Childhood asthma (age<16), excluding more controls

473

1.17

0.63

1.3

1.4

512.09

518.95

mu/l

0.03

456

Cardiac arrhythmias

159

917

1.11

0.62

1.4

499.77

641.18

mu/l

0.74

154

878

Childhood allergy (age < 16)

669

1.15

0.62

1.4

432.48

496.29

mu/l

0.61

634

Other maternal disorders predominantly related to pregnancy

175

991

1.10

0.62

1.4

1.5

444.12

549.04

mu/l

1.40

165

945

Malignant neoplasm of colon, including Hilmo

101

0.59

0.62

1.2

1.4

5378.17

655.47

mu/l

—

Other and unspecified tonsillitis

129

957

1.12

0.61

1.6

1.4

1014.12

556.51

mu/l

0.48

122

911

Pacemaker

202

1.29

0.60

1.5

1.4

390.79

1033.55

mu/l

0.70

191

Any death

381

0.83

0.60

1.2

1.5

553.40

1052.68

mu/l

0.81

368

Other obstetric trauma

163

0.67

0.60

1.3

1.6

441.55

481.28

mu/l

0.11

154

Impacted teeth

106

805

1.13

0.59

1.3

1.4

654.52

464.60

mu/l

0.45

101

768

265

1245

1.08

0.55

1.4

1057.34

589.79

mu/l

0.57

254

1184

Injuries to the elbow and forearm

171

1338

1.10

0.55

1.4

860.82

623.68

mu/l

0.59

158

1281

Calcific aortic valvular stenosis, diagnosis (helper)

121

1.35

0.51

2.4

1.2

449.76

539.34

mu/l

0.17

115

Operations 2 for CAVS

121

1.35

0.51

2.4

1.2

449.76

539.34

mu/l

0.17

115

Type 1 diabetes, strict (exclude DM2)

225

0.75

0.51

1.3

1.4

458.71

420.17

mu/l

0.18

212

Respiratory insufficiency

1.50

0.51

1.8

1.5

468.00

322.93

mu/l

—

Pruritus

170

1.30

0.51

1.2

1.5

286.05

427.32

mu/l

2.32

163

Peripheral artery disease

205

1.23

0.50

1.2

1.4

669.91

1422.35

mu/l

0.65

194

Calcific aortic valvular stenosis

122

1.34

0.49

2.4

1.2

449.76

535.11

mu/l

0.16

116

Calcific aortic valvular stenosis, operated

122

1.34

0.49

2.4

1.2

449.76

535.11

mu/l

0.16

116

Calcific aortic valvular stenosis, including rheumatic fever

122

1.34

0.49

2.4

1.2

449.76

539.48

mu/l

0.17

116

Fracture at wrist and hand level

696

1.13

0.48

1.3

1.4

706.18

594.79

mu/l

0.15

662

Premature rupture of membranes

680

0.89

0.48

1.2

1.5

343.58

519.46

mu/l

5.24

651

Fall on same level

306

1532

1.06

0.47

1.4

568.62

663.11

mu/l

0.37

293

1458

malignant neoplasm of male genital organs

128

0.75

0.47

1.1

1.5

329.94

815.46

mu/l

0.88

119

DVT of lower extremities

146

1.30

0.46

1.6

1.5

491.79

408.77

mu/l

0.26

140

Dislocation, sprain and strain of joints and ligaments of knee

163

1357

1.09

0.46

1.4

437.85

674.77

mu/l

1.71

153

1291

Oral corticosteroids

254

1393

1.07

0.46

1.4

509.04

706.16

mu/l

1.19

247

1320

Contact with and exposure to communicable diseases

101

1113

0.90

0.46

1.2

1.4

458.28

521.31

mu/l

0.35

1067

Insulin medication

103

772

1.11

0.44

1.3

1.5

409.24

788.58

mu/l

1.61

738

Methotrexate

157

1.27

0.43

1.9

1.4

526.10

459.65

mu/l

0.20

150

Acute and subacute iridocyclitis

248

1.21

0.42

1.2

1.4

554.49

423.33

mu/l

0.75

238

Malignant neoplasm of bronchus and lung

0.63

0.42

1.2

1.3

292.83

632.59

mu/l

—

Diabetes mellitus in pregnancy

151

885

1.08

0.42

1.3

1.4

504.86

544.07

mu/l

0.11

145

844

Hernia

158

1133

0.93

0.41

1.4

489.54

732.74

mu/l

1.21

150

1080

Caries of dentine, including avohilmo

144

677

1.09

0.41

1.3

1.4

406.17

504.76

mu/l

1.00

139

646

Type 1 diabetes, definitions combined

227

0.79

0.41

1.3

1.4

529.22

422.12

mu/l

0.48

214

Influenza and pneumonia

271

1578

1.06

0.39

1.4

567.12

658.47

mu/l

0.47

253

1510

Artificial joint operation, meniscal resection

108

756

0.91

0.39

1.5

501.83

806.67

mu/l

1.01

102

720

Artrosis, including avohilmo

145

858

0.92

0.39

1.6

1.5

561.38

799.41

mu/l

0.82

139

821

Disorders of synovium and tendon

115

894

1.09

0.39

1.5

1.4

662.73

804.77

mu/l

0.26

107

853

Finngen Rheumatological endpoints

231

1392

0.94

0.38

1.4

414.45

708.78

mu/l

2.49

225

1322

Injuries to the hip and thigh

570

1.12

0.38

1.5

1.4

410.22

771.20

mu/l

1.08

540

Respiratory distress of newborn

1.37

0.37

1.8

1.1

318.80

709.06

mu/l

—

Noninfective enteritis and colitis

102

932

1.09

0.37

1.3

1.4

451.08

602.24

mu/l

1.00

889

Conductive and sensorineural hearing loss

110

669

1.09

0.37

1.3

1.5

375.62

837.63

mu/l

1.86

105

640

Later onset COPD, excluding more controls

0.65

0.36

1.2

1.4

384.40

1353.67

mu/l

—

Chronic sinusitis

772

1.10

0.36

1.5

414.54

581.93

mu/l

1.78

738

Malignant neoplasm of colon

0.63

0.35

1.2

1.5

6421.80

734.25

mu/l

—

Tooth agenesis EXCLUDE clefts and syndromes

135

1.26

0.35

1.5

1.4

1146.65

420.27

mu/l

0.67

130

Presence of other functional implants

343

0.88

0.34

1.1

1.5

515.82

1056.99

mu/l

0.90

329

Maternal care related to the fetus and amniotic cavity and possible delivery problems

135

849

0.93

0.33

1.3

1.5

528.71

542.57

mu/l

0.03

126

812

Anterior Iridocyclitis

266

1.17

0.32

1.2

1.4

544.80

424.20

mu/l

0.70

256

Pedal cyclist injured in other and unspecified transport accidents

174

1.21

0.31

1.5

1.4

344.67

405.83

mu/l

0.64

168

Polyarthrosis

1.27

0.31

1.1

1.4

374.50

574.70

mu/l

1.41

Scoliosis

208

0.82

0.31

1.2

1.4

455.41

512.30

mu/l

0.12

199

Acute appendicitis, with complications

212

1.18

0.30

1.2

1.4

447.28

413.33

mu/l

0.16

203

Non-Hodgkin lymphoma, all, including Hilmo

1.31

0.30

1.4

311.55

635.89

mu/l

0.60

Malignant neoplasm of prostate, including Hilmo

110

0.80

0.30

1.1

1.5

363.80

885.15

mu/l

0.80

103

Medical abortion

159

912

0.94

0.28

1.4

1.5

408.86

557.71

mu/l

2.42

148

869

Multiple delivery

216

0.83

0.28

1.5

1.6

355.17

632.38

mu/l

1.53

201

Contraceptive management

102

664

1.07

0.27

1.3

1.5

530.91

564.41

mu/l

0.11

637

Chronic periodontitis, including avohilmo

198

1201

1.05

0.27

1.4

1.5

958.65

663.61

mu/l

0.41

188

1145

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

145

0.80

0.26

1.2

1.5

479.08

851.54

mu/l

0.67

137

Family history of malignant neoplasm

206

1.17

0.26

1.4

1.5

1822.50

454.15

mu/l

0.52

195

All influenza (not pneumonia)

235

1.15

0.25

1.2

1.4

541.74

546.49

mu/l

0.01

228

Flat foot [pes planus] (acquired)

1.25

0.24

1.9

1.4

1040.25

486.65

mu/l

0.48

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

236

1506

1.04

0.24

1.3

1.4

585.39

673.70

mu/l

0.41

219

1442

All pneumoniae

248

1546

1.04

0.24

1.3

1.4

581.57

664.30

mu/l

0.40

230

1481

Heterophoria

162

1.17

0.22

1.2

1.4

558.21

445.36

mu/l

0.28

156

Pregnancy with abortive outcome

187

931

1.05

0.22

1.3

1.5

409.86

557.54

mu/l

2.89

179

888

Fracture of femur

138

1.18

0.22

1.8

1.4

463.19

413.68

mu/l

0.15

130

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.21

0.0

1.1

—

379.70

—

Oral lichen planus and hypothyroidism or thyroxine medication

0.00

0.21

0.0

1.2

—

388.30

—

Injury, poisoning and certain other consequences of external causes

138

658

1.05

0.20

1.4

1.5

530.49

501.37

mu/l

0.11

133

632

Congenital malformations of eye, ear, face and neck

164

1.16

0.20

1.4

678.84

386.61

mu/l

0.99

158

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

110

0.82

0.20

1.5

1.4

8650.27

597.61

mu/l

0.45

102

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

115

0.78

0.20

1.1

1.4

383.44

631.32

mu/l

—

107

Pneumonias (Asthma/COPD co-morbidities)

244

1538

1.04

0.19

1.3

1.4

588.62

665.89

mu/l

0.36

226

1473

Crohn's disease of small intestine

118

1.19

0.19

1.4

600.79

412.86

mu/l

0.71

113

Other keratitis

185

1.14

0.18

1.1

1.5

619.20

409.84

mu/l

0.30

176

Seropositive rheumatoid arthritis

222

1.12

0.17

1.2

1.5

477.04

461.47

mu/l

0.05

214

Injury of muscle and tendon at lower leg level

186

1.13

0.17

1.4

1.5

500.71

375.87

mu/l

0.39

181

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

120

0.83

0.16

1.4

417.60

577.76

mu/l

—

112

Iridocyclitis

311

1.09

0.16

1.2

1.4

550.88

419.71

mu/l

0.89

297

Periodontitis

196

1207

1.03

0.16

1.4

1.5

963.28

662.06

mu/l

0.41

186

1151

Insulin, fast-acting (human)

264

1.10

0.15

1.3

1.5

453.07

441.63

mu/l

0.04

251

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

162

1059

0.97

0.15

1.4

1.5

481.28

770.93

mu/l

1.54

154

1006

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

123

1168

1.04

0.14

1.4

527.30

511.63

mu/l

0.06

117

1115

Seropositive rheumatoid arthritis, wide

227

1.10

0.14

1.2

1.5

477.04

443.28

mu/l

0.12

218

Secondary uncertain malignant neoplasm

100

0.80

0.13

1.6

1.4

489.25

590.87

mu/l

—

Other heart diseases, wide

211

1311

0.97

0.13

1.5

1.4

505.38

596.70

mu/l

0.59

205

1245

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

190

1.11

0.12

1.9

1.6

425.48

465.57

mu/l

0.18

183

Complications of labour and delivery

169

911

1.03

0.12

1.4

1.5

526.63

541.09

mu/l

0.04

163

869

Fracture of forearm

103

960

0.96

0.12

1.4

767.33

461.33

mu/l

0.80

920

Hallux valgus (acquired)

239

0.93

0.12

1.9

1.5

739.70

556.93

mu/l

0.27

230

Striking against or struck by other objects

795

1.04

0.12

1.3

1.4

413.42

515.29

mu/l

0.86

763

Maternal care for other known or suspected fetal problems

114

740

0.97

0.12

1.3

1.5

628.69

523.84

mu/l

0.24

105

708

Persons with potential health hazards related to communicable diseases

123

1258

0.97

0.11

1.2

1.5

435.41

517.04

mu/l

0.62

114

1206

Asthma/COPD (KELA code 203)

232

1514

1.02

0.11

1.5

1.4

597.31

668.06

mu/l

0.30

224

1442

Bitten or struck by other mammals

259

1.08

0.11

1.4

512.16

414.36

mu/l

0.44

245

malignant neoplasm of male genital organs, including Hilmo

132

0.91

0.11

1.2

1.5

336.60

802.32

mu/l

0.88

123

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

221

1.09

0.11

1.3

1.4

490.58

446.60

mu/l

0.16

212

Diseases of the respiratory system

146

711

1.03

0.10

1.3

1.5

411.16

607.83

mu/l

1.63

140

683

Arthrosis

114

606

1.03

0.09

1.4

1.5

486.57

937.87

mu/l

1.36

109

576

Injuries to the shoulder and upper arm

166

1251

1.02

0.09

1.4

829.03

664.09

mu/l

0.31

156

1191

Cholelithiasis, broad definition with cholecystitis

148

961

1.02

0.09

1.5

555.74

732.67

mu/l

0.68

143

915

Other/unspecified seropositive rheumatoid arthritis

224

1.07

0.08

1.3

1.5

490.58

444.15

mu/l

0.17

215

Inflammatory bowel disease treatment related agents

271

1526

0.98

0.08

1.4

488.36

679.69

mu/l

1.31

264

1449

Non-small cell lung cancer, including Hilmo

0.80

0.07

1.2

1.3

292.83

709.13

mu/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

122

0.90

0.07

1.4

644.09

380.31

mu/l

0.82

116

Lung cancer and mesothelioma

0.85

0.06

1.6

1.4

303.38

1072.07

mu/l

—

Sulfonylureas

128

0.93

0.05

1.2

1.3

379.27

1782.06

mu/l

0.90

119

Ulcerative rectosigmoiditis

120

0.92

0.05

1.2

1.4

358.45

409.25

mu/l

0.34

115

Any event in cancer register

205

1210

0.99

0.04

1.5

1.4

499.94

583.46

mu/l

0.66

200

1150

Pregnancy hypertension

115

1043

0.98

0.04

1.5

1.4

534.38

537.28

mu/l

0.01

110

995

Peritonsillar abscess

497

1.03

0.04

1.2

1.4

450.69

525.36

mu/l

0.37

478

Labour and delivery complicated by fetal stress [distress]

110

726

0.98

0.03

1.3

1.5

633.03

516.76

mu/l

0.28

104

693

Atherosclerosis, excluding cerebral and coronary sclerosis

173

0.95

0.03

1.1

1.4

493.33

1604.46

mu/l

0.97

164

Single delivery by caesarean section

528

1.02

0.03

1.3

1.5

384.34

571.63

mu/l

2.34

503

Placenta praevia

169

0.95

0.03

1.2

1.7

397.56

501.52

mu/l

0.43

160

Deep endometriosis

169

0.95

0.03

1.1

1.6

925.47

463.20

mu/l

0.34

164

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

132

1.06

0.02

1.3

1.5

530.93

404.39

mu/l

0.39

126

malignant neoplasm of female genital organs, including Hilmo

112

0.94

0.02

1.5

1.4

287.73

509.70

mu/l

2.38

107

Special screening examination for other diseases and disorders

182

1.04

0.02

1.6

1.5

784.32

424.97

mu/l

1.55

175

1.06

0.01

1.2

1.5

569.18

651.53

mu/l

0.09

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

123

1059

1.01

0.01

1.5

1.4

535.92

537.00

mu/l

0.00

118

1010

Other Crohn's disease

124

1.05

0.00

1.8

1.4

574.46

406.23

mu/l

0.55

119

Other disorders of ear

158

1016

1.00

0.00

1.4

1.5

408.67

756.80

mu/l

2.15

148

968

Malignant neoplasm of respiratory system and intrathoracic organs

0.95

0.00

1.5

1.4

8650.27

590.47

mu/l

0.45

Aortic aneurysm

148

0.99

0.00

1.1

1.5

263.47

511.88

mu/l

0.96

143

Crohn disease (strict definition, require KELA)

124

0.97

0.00

1.3

1.5

597.25

392.56

mu/l

0.63

118

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

231

1461

1.00

0.00

1.4

725.56

653.90

mu/l

0.16

224

1391

Systemic sclerosis,strict definition

0.00

0.0

1.2

—

409.80

—

Posteruptive colour changes of dental hard tissues

0.00

-0.00

0.0

1.2

—

343.78

—

Other autoimmune haemolytic anaemias

0.00

-0.00

0.0

1.6

—

446.86

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

1.2

—

336.60

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

-0.00

0.0

1.2

—

725.00

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.2

—

210.60

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.3

—

360.83

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.3

—

370.57

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

-0.00

0.0

1.3

—

395.33

—

Ankylosis of teeth

0.00

-0.00

0.0

1.3

—

349.50

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prolactin monomeric [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS